Public Companies
Jupiter Acquisition Files Investor Presentation on Filament Health Deal
Jupiter Acquisition in a regulatory filing included an investor presentation promoting its proposed merger with Filament Health, a Canadian clinical‐stage…
Jupiter Acquisition in a regulatory filing included an investor presentation promoting its proposed merger with Filament Health, a Canadian clinical‐stage psychedelic drug development company.
The combination had a pro forma enterprise value of about $210 million at deal announcement in July.
The deal is expected to provide at least $5 million of net proceeds to the combined company. The proposed combination reflects a pre-money equity value of $176 million for Filament and provides the company’s shareholders and certain other parties a contingent right to receive additional shares based upon post-closing stock performance. At closing, holders of outstanding Filament shares will receive equity in the merged company valued at 85 cents per share (subject to adjustments).
Filament is a natural psychedelic drug development company focused on the treatment of substance use disorders. Filament’s proprietary technology platform enables the discovery and delivery of botanical psychedelic medicines. Read more.
-
Psychedelics1 week ago
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Law & Regulation1 week ago
Tryp Therapeutics merger with Exopharm approved by shareholders
-
Psychedelics1 week ago
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
-
Law & Regulation1 week ago
Tryp Therapeutics, Exopharm merger approved by shareholders
-
Law & Regulation1 week ago
Adastra reports record sales in 2023, but remains in the red
-
Psychedelics1 week ago
MindBio Landmark Sleep Research Published in Prestigious Nature Portfolio Journal Translational Psychiatry
-
LSD1 week ago
The First Wave of Blotter Acid Inspired Trippy Psychedelic Art
-
Psilocybin6 days ago
Psychedelic Underground Celebrated in San Francisco on Bicycle Day Weekend